NCT00374530CompletedNot Applicable
Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Danish Headache Center
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Headache
Study Overview
Brief Summary
Before, during and after intravenous administration of PGE2 we score/measure headache, rCBF, blood flow in the middle cerebral artery and diameter of superficial temporal artery and correlate that to known pathophysiology of headache to see if PGE2 is involved in headache pathophysiology.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Healthy volunteers
Exclusion Criteria
- •Primary Headache, headache on the day of the investigation, hypertension, hypotension, pregnant/nursing, daily intake of medication (except oral contraceptives), Cardiovascular or CNS disease, drug/alcohol abuse, psychiatric disease
Outcomes
Primary Outcomes
Headache
Secondary Outcomes
- rCBF, blood flow, diameter of STA/RA, HR, BP
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Phase 1
PGI2 Induced Headache and Cerebral Haemodynamics in Healthy VolunteersHeadacheMigraineNCT00291395Danish Headache Center12
Completed
Not Applicable
Prostaglandin E2 in Migraine Suffers Without Aura."Migraine-like" HeadacheNCT01384812Troels Wienecke12
Unknown
Not Applicable
Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2HeadacheVasodilatationMigraineNCT00510172Glostrup University Hospital, Copenhagen12
Completed
Not Applicable
Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood FlowHeadacheMigraineNCT01637662Danish Headache Center6
Completed
Not Applicable
Prostaglandin F2alpha in a Human Headache ModelHeadacheNCT01327118Danish Headache Center12
